EDX
EDX Medical Group Plc
Access
ISIN
GB00BNDMJS47
Bid
5.25
Mid
5.625
Ask
6.00
Key Information
- Price Change
- 0.00%
- Year High
- 5.75
- Year Low
- 2.50
- Last Trade
- 30 Nov 23
- Market Cap
- £16.93M
- Par
- 0.01
- Bid
- 5.25
- Mid Price
- 5.625
- Ask
- 6.00
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 301.0M
- Sector
- Healthcare
Prices in GBX except for Market Cap in GBP
About EDX Medical Group Plc
EDX Medical develops and delivers innovative digital diagnostic products and services for cancer, heart disease, neurology and infectious disease testing, helping to predict disease risk, inform clinical decision-making and accelerate the development of new medicines. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection of disease risk and personalise disease management in a timely fashion. Early disease detection and risk prediction is the most impactful way of reducing deaths and lowering the future costs of healthcare provision globally. EDX Medical operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development (R&D), provides testing and genomic sequencing services, undertakes quality assurance and has established expertise in the design, development, validation and sourcing of diagnostic tests at commercial scale. Key tests performed in this laboratory have been audited by the United Kingdom Accreditation Service (UKAS) and accredited to ISO 15189.
Latest Trades
Date | Volume | Price (GBX) | Value (GBP) |
---|---|---|---|
30 Nov 23 15:18 | 60,000 | 5.50 | 3,300.00 |
30 Nov 23 15:12 | 50,000 | 5.70 | 2,850.00 |
28 Nov 23 16:24 | 150,000 | 5.50 | 8,250.00 |
24 Nov 23 16:20 | 40,000 | 5.50 | 2,200.00 |
24 Nov 23 09:44 | 100,000 | 5.25 | 5,250.00 |
Latest Announcements & Notices
Date | Title |
---|---|
21 Nov 23 07:00 | EDX Medical Group - EDX Medical-Thermo Fisher Scientific collaboration |
25 Oct 23 15:00 | EDX Medical Group - General Meeting results |
18 Oct 23 17:33 | EDX Medical Group - Change of venue of General Meeting |
05 Oct 23 07:00 | EDX Medical Group - Agreement to distribute cancer genomic tests |
- |
Address
Registered Address
Unit 210-211 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA, United KingdomPhone
Contacts
Corporate Adviser
Oberon Capital, Nightingale House, 65 Curzon Street, London, W1J 8PE, United KingdomRegistrar
Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom